COMMUNIQUÉS West-GlobeNewswire

Optinose to Present at Leerink Partners 7th Annual Global Healthcare Conference
09/02/2018
YARDLEY, Pa., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive [...]
Ogilvy CommonHealth Worldwide’s Reilly and Logan Inducted Into the Medical Advertising Hall of Fame's Future Famers Program
09/02/2018
PARSIPPANY, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP ) ( www.wpp.com ), today announced Lindsey Reilly, senior [...]
LeMaitre Vascular Will Announce Fourth Quarter 2017 Earnings Results on February 21, 2018
09/02/2018
BURLINGTON, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ) announced today that it will release its fourth quarter 2017 financial results on Wednesday, February 21, 2018, after the [...]
Immune Design to Present at Upcoming Investor Conferences
09/02/2018
SEATTLE and SOUTH SAN FRANCISCO, Calif., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ ), an immunotherapy company focused on next-generation therapies in oncology, today announced that senior management [...]
The American Health Council Appoints Michael Mahla, MD to Physician Board
09/02/2018
NEW YORK, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Michael Mahla, MD is selected to the American Health Council’s Board of Physicians for his outstanding contributions to the medical field. As a professor and executive vice [...]
Enhanced MuScreen™ Platform Revolutionizes Preclinical Development of Immunotherapeutics
09/02/2018
SAN DIEGO, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]
Catalyst Biosciences Announces Positive Top-Line Data from Phase 1/2 Study of Subcutaneous CB 2679d/ISU304 in Individuals with Hemophilia B
09/02/2018
All individuals with severe hemophilia improved to mild hemophilia activity levels after only six daily doses with a continuous linear increase in Factor IX clotting activity These results suggest that long-term dosing [...]
Summit Therapeutics to Participate in Upcoming Investor Conferences
09/02/2018
Summit Therapeutics plc ("Summit", or the "Company") SUMMIT THERAPEUTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES Oxford, UK, 9 February 2018 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug [...]
Summit Therapeutics to Participate in Upcoming Investor Conferences
09/02/2018
OXFORD, United Kingdom, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM), the drug discovery and development company advancing therapies for rare diseases and infectious diseases, [...]
Bio-Path Holdings Announces 1-for-10 Reverse Stock Split
09/02/2018
HOUSTON, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Chembio Diagnostics Announces Pricing of its Public Offering of Common Stock
09/02/2018
MEDFORD, N.Y., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI ) (“Chembio”), a leader in point-of-care diagnostic tests for infectious diseases, announced today the pricing of its previously [...]
Lotus Enters “Active Review” with Health Canada & Closes Cannabis Financing of $1 Million
09/02/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Lotus Ventures Inc (CSE:J) (the " Company ") announced today that [...]
pSivida to Present at the 2018 BIO CEO & Investor Conference
09/02/2018
WATERTOWN, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ: PSDV ) (ASX:PVA), a leader in the development of sustained release drug products and technologies, announced today that Nancy Lurker, President [...]
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2017
09/02/2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ: AGTC ), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]
Novo Nordisk A/S: Ozempic® (semaglutide) approved in the EU for the treatment of type 2 diabetes
09/02/2018
Bagsværd, Denmark, 9 February 2018 - Novo Nordisk today announced that the European Commission (EC) has granted marketing authorisation for Ozempic ® (semaglutide) for the treatment of adults with type 2 diabetes. [...]
Achillion to Present at the Leerink Partners 7th Annual Global Healthcare Conference
09/02/2018
NEW HAVEN, Conn., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN ) announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will participate in a [...]
ContraVir Pharmaceuticals to Present at BIO CEO & Investor Conference
09/02/2018
EDISON, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]
Calithera to Participate in Leerink Partners 7th Annual Global Healthcare Conference
09/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, today announced [...]
Ambu A/S: Articles of Association February 2018
09/02/2018
Articles of Association February 2018 Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/ef9a3672-1646-4832-92e3-9680a37d2a9a

Pages